Clinical Trial Update: Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers [Phase 1]

View source ↗

Summary

Phase 1 crossover study to compare the bioavailability of two fixed-dose combination tablets containing extended-release metformin and extended-release glimepir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin Extended Release (metformin)
• glimepiride extended-release (glimepiride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: TERMINATED